Hi Ajostu,
Yes I remember you well from right bock in the POS days if memory serves me right; we’ve certainly come a long way since then and yes we’re dependent on Acadia if we need to keep NEU’s income constant or increasing, so are Acadia dependent on our products to keep their income increasing, if the relationship falls apart Acadia is more screwed than we are given they need more and more money to keep expanding; NEU has a trove of cash, low cash burn and plenty in reserve to fund the planned P3 trial and more.
I fully support the SBB and actually believe it may be increased in the future.
NEU has made it clear the company will be sold for the right price when certain inflection points are met, this may be in 6, 12, 18 months, in the meantime they are doing their best to stop the top end of town from decimating the faithful retail holders confidence, in the end I believe we will win out handsomely.
- Forums
- ASX - By Stock
- NEU
- Why NEU shareholders should love the buyback !!!
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.00%
!
$12.54

Why NEU shareholders should love the buyback !!!, page-17
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.54 |
Change
0.000(0.00%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
$12.61 | $12.68 | $12.32 | $7.219M | 577.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2968 | $12.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.57 | 540 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2968 | 12.510 |
1 | 1399 | 12.490 |
1 | 1592 | 12.480 |
1 | 1342 | 12.470 |
4 | 3622 | 12.450 |
Price($) | Vol. | No. |
---|---|---|
12.570 | 540 | 1 |
12.580 | 1000 | 1 |
12.620 | 1592 | 1 |
12.630 | 2217 | 6 |
12.640 | 1592 | 1 |
Last trade - 16.16pm 25/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online